4379219
Last Update Posted: 2020-05-07
Recruiting status is unknown
Females accepted | Under |
56 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy
There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez & Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).
This will be a randomized clinical trial to evaluate the effect of administration of methotrexate before surgery in reducing bleeding, injury to bladder and ureter, operative time and removing of CSP mass.This will be in comparison to surgery alone in cases of first trimester cesarean scar pregnancy
Eligibility
Relevant conditions:
Cesarean Scar Pregnancy
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
Maher Elesawi Elgaly, M.D MRCOG
mahereleswi@yahoo.com
+2 01016406182
Data sourced from ClinicalTrials.gov